Wednesday, July 2, 2025 7/2/2025

Rapid Culture-Independent Detection of Sepsis Causing Microorganism Directly from Blood

Award Number: R35GM155460
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2024
PERIOD OF PERFORMANCE END DATE: 05/31/2029

Group Awards By:

View Award Description

Rapid Culture-Independent Detection of Sepsis Causing Microorganism Directly from Blood - ABSTRACT Sepsis is a rapid-developing and life-threatening condition and is one of the most common causes of death in hospitalized patients in the US. Sepsis is generally caused by bacterial, fungal, or viral infection. For well over half a century, blood culture has been the main diagnostic method, but can only inform us of the presence of microorganism growth. Although empirical antibiotic treatments are usually started as soon as patients presenting with signs of severe sepsis, gaps remain in our ability to rapidly identify sepsis-causing pathogens to guide treatment with higher precision. Studies have shown significant risks to septic patients associated with delayed results and inappropriate therapy, with each hour of delay in administration of appropriate antibiotics associated with increased mortality. Although molecular diagnostic technologies are available to improve identification accuracy, they still rely on a positive blood culture result which may take 12 to 48 h or even longer if the initial culture is unsuccessful. In this MIRA R35 project, we propose to develop novel nanopore- and click- chemistry-based approaches for accurate detection of sepsis-causing pathogen independent of blood culture in about 2 hours to support the early administration of source-directed antibiotics. To fit in the clinical sepsis treatment procedure, we will employ rapid automatic sample preparation and assay methods. Our methodology will target proteomic biomarkers, such as outer membrane proteins and virulence factors released into circulation, as they are less prone to interference of blood components compared to bacterial genomic materials, and are only secreted by viable microorganisms. The PI will accomplish the proposed goal by engineering nanopore biosensors meet clinical needs of sepsis causing pathogen detection and developing multiplex click chemistry amplified nanopore sensing for sepsis causing microorganism detection and prognosis. The scientific and clinical promises of our research lie in the innovative biosensing mechanism with unprecedented sensitivity for detecting sepsis causing pathogen protein biomarkers directly in blood; the user-friendly device prototype readily applicable in clinical settings; and the discovery of potential prognosis value of virulence factors. In the past years, the PI has established a successful research trajectory by mentoring a postdoctoral fellow and six PhD students, publishing high-impact research papers, and securing competitive research grants. We will utilize our group’s diverse expertise on biochemistry, proteomics, nanotechnology, and microelectronics in conjunction with our collaborators’ expertise on high specificity high affinity binding ligands and sepsis clinical diagnosis and treatment to ensure the success of proposed research. The nanopore biosensing platform resulting from this project will also benefit the general in vitro diagnostics field by offering a sensitive, user-friendly, cost-effective, and robust method for assaying protein biomarkers in biological samples.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $451,990 )
2025	2025	UNIVERSITY OF MASSACHUSETTS	101 COMMONWEALTH AVE	AMHERST	MA	01003	HAMPSHIRE	USA	Biomedical Research and Research Training	005	3	5/22/2025	NON-COMPETING CONTINUATION	$406,041
2025	2024	UNIVERSITY OF MASSACHUSETTS	101 COMMONWEALTH AVE	AMHERST	MA	01003	HAMPSHIRE	USA	Biomedical Research and Research Training	003	2	3/24/2025	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$1
2025	2024	UNIVERSITY OF MASSACHUSETTS	101 COMMONWEALTH AVE	AMHERST	MA	01003	HAMPSHIRE	USA	Biomedical Research and Research Training	001	2	12/13/2024	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$403,748
2025	2024	UNIVERSITY OF MASSACHUSETTS	101 COMMONWEALTH AVE	AMHERST	MA	01003	HAMPSHIRE	USA	Biomedical Research and Research Training	004	2	4/24/2025	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$0
2025	2024	UNIVERSITY OF SOUTH CAROLINA	1600 HAMPTON ST	COLUMBIA	SC	29208	RICHLAND	USA	Biomedical Research and Research Training	002	1	3/24/2025	NEW	-$1
2025	2024	UNIVERSITY OF SOUTH CAROLINA	1600 HAMPTON ST	COLUMBIA	SC	29208	RICHLAND	USA	Biomedical Research and Research Training	000	1	12/13/2024	NEW	-$357,799
														Subtotal = $451,990

Issue Date FY: 2024 ( Subtotal = $357,800 )
2024	2024	UNIVERSITY OF SOUTH CAROLINA	1600 HAMPTON ST	COLUMBIA	SC	29208	RICHLAND	USA	Biomedical Research and Research Training	000	1	6/27/2024	NEW	$357,800
														Subtotal = $357,800

Grand Total All Awards = $809,790

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Rapid Culture-Independent Detection of Sepsis Causing Microorganism Directly from Blood

Award Number: R35GM155460

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2024

PERIOD OF PERFORMANCE END DATE: 05/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer